SANA — Sana Biotechnology Share News
0.000.00%
Last trade - 00:00- $709.48m
- $548.99m
Brief: Sana Biotechnology Announces Pricing Of Public Offering At $3.35 Per Share
Sana Biotechnology after launching $75 mln stock deal
Brief: Seres Therapeutics QTRLY Loss Per Share $2.27
Sana Biotechnology Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Sana Biotechnology Says Six-Month Results Show Islet Cells Safe & Functional
Brief: Sana Biotechnology to present at 85th annual American Diabetes Association Scientific Sessions
Sana Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Sana Biotechnology Q1 Operating Expenses USD 50.63 Million
Sana Biotechnology Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Sana Biotechnology Announces Positive Clinical Results From Type 1 Diabetes Study Of Islet Cell Transplantation Without Immunosuppression
Brief: Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
Sana Biotechnology Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Sana Biotechnology Q3 Adjusted EPS USD -0.27 Vs. IBES Estimate USD -0.25
Brief: Sana Biotechnology Announces Increased Focus On Type 1 Diabetes And B-Cell Mediated Autoimmune Diseases With The Potential To Deliver Clinical Proof Of Concept Data Across Multiple Studies In 2024 And 2025
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence
Brief: Sana Biotechnology Inc Says Susan Wyrick Appointed Interim CFO Of Co
Brief: Sana Biotechnology- On Sept 6, Nathan Hardy Notified He Intends To Resign From His Position As Executive Vice President And CFO
Sana Biotechnology Inc expected to post a loss of 27 cents a share - Earnings Preview
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.32 Vs. IBES Estimate USD -0.28